Register now to learn about a new option for relapsed or refractory follicular lymphoma

When to Consider a Clinical Trial?

Tuesday, December 09, 2014
Considering participation in a clinical trial is often a very difficult decision for patients, especially those dealing with a rare disease. In this video, leading CTCL experts address the question of when a patient should consider entering a clinical trial.

The video features expert insights from:
  • Larisa Geskin, MD, Associate Professor of Dermatology, University of Pittsburgh
  • Stuart Lessin, MD, Medical Director, KGL Skin Study Center, Broomall, PA
  • Pierluigi Porcu, MD, Associate Professor of Internal Medicine, Division of Hematology-Oncology, Ohio State University Comprehensive Cancer Center
  • Marianne Tawa, RN, MSN, ANP, Nurse Practitioner, Dermatology and Cutaneous Oncology, Dana Farber Cancer Institute
This video is one of several featured in the CLF’s Online Learning Center. Other topics include recommendations for managing itch and a three-part overview of treatments for cutaneous lymphoma.
For more information, visit
External Resources

MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
OncNurse Resources

Continuing Education
Web Exclusives

About Us
Advisory Board
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.